In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...
Pfizer Inc. (NYSE:PFE – Get Free Report) saw unusually large options trading activity on Thursday. Traders acquired 251,131 ...
In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...
Hosted on MSN1mon
Pfizer Stock: Is PFE Underperforming the Healthcare Sector?With a market cap of $144.8 billion, New York ... Pfizer raised its full-year revenue guidance to $61 billion - $64 billion and adjusted EPS guidance to $2.75 - $2.95. However, the stock fell ...
That's especially the case when you invest in stocks that pay you to own them. I'm referring to dividend stocks, of course.
Citi analyst Geoff Meacham maintained a Hold rating on Pfizer (PFE – Research Report) today. The company’s shares closed yesterday at ...
It doesn't matter your age or experience: taking full advantage of the stock market and investing ... attractive and discounted stocks. New York-based Pfizer markets a wide range of drugs and ...
The stock has lost 12% this year through Monday. Starboard Value's Chief Executive Jeff Smith has publicly accused Pfizer of squandering its Covid successes and has suggested that CEO Albert ...
Pfizer on Tuesday appealed a federal judge's refusal to award the drugmaker $75.2 million from a more than decade-old insider ...
Taking full advantage of the stock market and investing with confidence ... favorable times to buy high-momentum stocks. New York-based Pfizer markets a wide range of drugs and vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback